NBTX
Nanobiotix S.A.
Price Chart
Latest Quote
$34.47
+2.94 (+9.32%)
Current Price
| Previous Close | $31.53 |
| Open | $33.13 |
| Day High | $34.60 |
| Day Low | $32.32 |
| Volume | 117,794 |
Stock Information
Note: Financial values converted from EUR to USD
| Shares Outstanding | 50.95M |
| Total Debt | $118.64M |
| Cash Equivalents | $123.40M |
| Revenue | $12.80M |
| Net Income | $-58.83M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.76B |
| EPS (TTM) | $-1.27 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.75B |
| Sales | $12.80M |
| Income | $-58.83M |
| Book/sh | $-0.74 |
| Cash/sh | $2.18 |
| Employees | 98 |
Financial Ratios
| Quick Ratio | 1.40 |
| Current Ratio | 1.44 |
Returns & Margins
| ROA | -21.34% |
| Gross Margin | 100.00% |
| Operating Margin | -322.88% |
Ownership
| Institutional Ownership | 11.95% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -205.87 |
| P/S | 152.89 |
| P/B | -46.78 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $53.84 |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| SMA200 | $nan |
| RSI | 69.80 |
| ATR | nan |
| Shares Float | 35.15M |
| Short Float | 0.39% |
| Short Ratio | 1.10 |
| Volatility | 0.59 |
| Rel Volume | 0.86 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| 6 Months | nan% |
| YTD | nan% |
| Year | nan% |
| 3 Years | nan% |
| 5 Years | nan% |
| 10 Years | nan% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $nan | 129,979 |
| 2026-10-26 | $31.53 | 129,700 |
| 2026-10-23 | $29.36 | 69,400 |
| 2026-10-22 | $29.19 | 216,500 |
| 2026-10-21 | $25.83 | 165,300 |
| 2026-10-20 | $24.14 | 137,900 |
| 2026-10-19 | $21.08 | 44,800 |
| 2026-10-16 | $21.30 | 77,800 |
| 2026-10-15 | $22.23 | 116,400 |
| 2026-10-14 | $21.28 | 80,600 |
| 2026-10-13 | $21.49 | 231,300 |
| 2026-10-12 | $23.40 | 173,300 |
| 2026-10-09 | $23.68 | 93,500 |
| 2026-10-08 | $22.90 | 116,600 |
| 2026-10-07 | $24.62 | 142,600 |
| 2026-10-06 | $25.23 | 156,300 |
| 2026-10-05 | $25.10 | 194,200 |
| 2026-10-02 | $25.75 | 255,800 |
| 2026-10-01 | $27.90 | 192,400 |
| 2026-09-30 | $31.16 | 311,400 |
| 2026-09-29 | $31.50 | 163,500 |
| 2026-09-28 | $32.60 | 49,400 |
About Nanobiotix S.A.
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
đ° Latest News
No news articles available at the moment. Check back later for updates on NBTX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $33,295,519 | $-13,040,548 | $33,761,654 | $0 |
| Operating Revenue | $25,476,806 | $-19,694,485 | $33,415,703 | $0 |
| Expenses | ||||
| Interest Expense | $11,675,840 | $9,082,332 | $8,965,517 | $6,556,217 |
| Total Expenses | $45,446,479 | $63,778,502 | $63,839,156 | $52,457,599 |
| Other Income Expense | $-3,632,483 | $3,352,802 | $-7,100,977 | $2,365,495 |
| Net Non Operating Interest Income Expense | $-11,126,587 | $-2,948,444 | $-7,278,446 | $-13,968,325 |
| Total Other Finance Cost | $557,116 | $-3,180,950 | $-320,117 | $7,699,652 |
| Interest Expense Non Operating | $11,675,840 | $9,082,332 | $8,965,517 | $6,556,217 |
| Operating Expense | $45,446,479 | $63,778,502 | $63,839,156 | $52,457,599 |
| Other Operating Expenses | $-453,780 | $-940,133 | $503,201 | $385,263 |
| General And Administrative Expense | $22,713,692 | $22,530,608 | $24,330,001 | $19,633,831 |
| Rent Expense Supplemental | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-26,913,400 | $-76,527,014 | $-44,591,711 | $-64,069,415 |
| Net Interest Income | $-11,126,587 | $-2,948,444 | $-7,278,446 | $-13,968,325 |
| Interest Income | $1,106,369 | $2,952,937 | $1,366,955 | $287,544 |
| Normalized Income | $-24,189,038 | $-79,041,616 | $-39,265,978 | $-65,843,536 |
| Net Income From Continuing And Discontinued Operation | $-26,913,400 | $-76,527,014 | $-44,591,711 | $-64,069,415 |
| Total Operating Income As Reported | $2,349,770 | $-76,819,050 | $-30,078,625 | $-52,456,476 |
| Net Income Common Stockholders | $-26,913,400 | $-76,527,014 | $-44,591,711 | $-64,069,415 |
| Net Income | $-26,913,400 | $-76,527,014 | $-44,591,711 | $-64,069,415 |
| Net Income Including Noncontrolling Interests | $-26,913,400 | $-76,528,137 | $-44,591,711 | $-64,071,662 |
| Net Income Continuous Operations | $-26,913,400 | $-76,528,137 | $-44,591,711 | $-64,071,662 |
| Pretax Income | $-26,910,030 | $-76,414,692 | $-44,456,925 | $-64,060,429 |
| Interest Income Non Operating | $1,106,369 | $2,952,937 | $1,366,955 | $287,544 |
| Operating Income | $-12,150,960 | $-76,819,050 | $-30,077,502 | $-52,457,599 |
| Depreciation Amortization Depletion Income Statement | $387,510 | $358,306 | $303,269 | $376,278 |
| Depreciation And Amortization In Income Statement | $387,510 | $358,306 | $303,269 | $376,278 |
| Amortization Of Intangibles Income Statement | $1,123 | $1,123 | $0 | $1,123 |
| Depreciation Income Statement | $386,387 | $357,183 | $303,269 | $375,154 |
| Special Income Charges | - | - | $0 | $0 |
| Per Share | ||||
| Diluted EPS | $-0.56 | $-1.62 | $-1.21 | $-1.84 |
| Basic EPS | $-0.56 | $-1.62 | $-1.21 | $-1.84 |
| Other | ||||
| Tax Effect Of Unusual Items | $-908,121 | $838,201 | $-1,775,244 | $591,374 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-9,922,498 | $-68,864,428 | $-26,691,003 | $-58,184,882 |
| Total Unusual Items | $-3,632,483 | $3,352,802 | $-7,100,977 | $2,365,495 |
| Total Unusual Items Excluding Goodwill | $-3,632,483 | $3,352,802 | $-7,100,977 | $2,365,495 |
| Reconciled Depreciation | $1,679,209 | $1,820,735 | $1,699,427 | $1,684,825 |
| EBITDA (Bullshit earnings) | $-13,554,982 | $-65,511,626 | $-33,791,980 | $-55,819,387 |
| EBIT | $-15,234,191 | $-67,332,360 | $-35,491,408 | $-57,504,212 |
| Diluted Average Shares | $53,711,813 | $53,089,059 | $41,478,335 | $39,066,717 |
| Basic Average Shares | $53,711,813 | $53,089,059 | $41,478,335 | $39,066,717 |
| Diluted NI Availto Com Stockholders | $-26,913,400 | $-76,527,014 | $-44,591,711 | $-64,069,415 |
| Tax Provision | $3,370 | $113,445 | $134,786 | $11,232 |
| Gain On Sale Of Security | $-3,632,483 | $3,352,802 | $-7,100,977 | $2,365,495 |
| Other Taxes | $-3,164,102 | $-3,706,616 | $-4,424,351 | $-4,595,080 |
| Amortization | $1,123 | $1,123 | $0 | $1,123 |
| Research And Development | $25,963,159 | $45,536,336 | $43,127,036 | $36,657,307 |
| Selling General And Administration | $22,713,692 | $22,530,608 | $24,330,001 | $19,633,831 |
| Other Gand A | $8,981,242 | $9,067,730 | $11,107,492 | $8,752,106 |
| Salaries And Wages | $13,732,450 | $13,462,878 | $13,222,509 | $10,881,725 |
| Rent And Landing Fees | - | - | - | - |
Fetched: 2026-10-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-94,903,966 | $-73,806,582 | $-2,080,198 | $-30,378,524 |
| Total Assets | $76,109,177 | $75,725,037 | $105,466,697 | $67,133,551 |
| Total Non Current Assets | $5,627,317 | $6,684,264 | $7,366,056 | $8,325,284 |
| Other Non Current Assets | $28,080 | - | - | - |
| Non Current Prepaid Assets | $459,396 | $456,026 | $335,842 | $326,856 |
| Goodwill And Other Intangible Assets | $11,232 | $7,863 | $8,986 | $1,123 |
| Other Intangible Assets | $11,232 | $7,863 | $8,986 | $1,123 |
| Current Assets | $70,481,860 | $69,039,650 | $98,100,641 | $58,809,390 |
| Other Current Assets | $2,246 | $-1,123 | $1,123 | $1,123 |
| Prepaid Assets | $2,603,617 | $3,588,678 | $2,875,435 | $3,348,310 |
| Receivables | $8,626,306 | $9,586,656 | $10,664,944 | $8,972,257 |
| Other Receivables | $1,601,707 | $1,218,690 | $3,908,795 | $3,078,738 |
| Taxes Receivable | $4,625,407 | $5,024,149 | $5,739,638 | $5,780,074 |
| Accounts Receivable | $2,399,191 | $3,343,817 | $1,016,511 | $113,445 |
| Cash Cash Equivalents And Short Term Investments | $59,249,691 | $55,865,439 | $84,559,138 | $46,487,701 |
| Cash And Cash Equivalents | $59,249,691 | $55,865,439 | $84,559,138 | $46,487,701 |
| Cash Equivalents | $58,339,886 | $49,901,157 | $0 | $3,159,609 |
| Cash Financial | $909,806 | $5,963,159 | $84,559,138 | $43,329,215 |
| Investmentin Financial Assets | - | - | $0 | $0 |
| Debt | ||||
| Net Debt | $44,333,371 | - | - | $7,020,106 |
| Total Debt | $107,063,912 | $57,173,987 | $56,795,463 | $59,719,196 |
| Long Term Debt And Capital Lease Obligation | $102,223,970 | $51,643,267 | $51,154,667 | $54,597,327 |
| Long Term Debt | $100,102,213 | $48,308,436 | $46,793,216 | $49,466,472 |
| Current Debt And Capital Lease Obligation | $4,839,942 | $5,530,720 | $5,640,795 | $5,121,869 |
| Current Debt | $3,480,849 | $4,114,344 | $4,294,058 | $4,041,334 |
| Other Current Borrowings | $3,480,849 | $4,114,344 | $4,294,058 | $4,041,334 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $171,001,911 | $149,523,757 | $107,537,909 | $97,510,952 |
| Total Non Current Liabilities Net Minority Interest | $106,409,076 | $83,326,969 | $51,519,713 | $54,900,596 |
| Other Non Current Liabilities | $3,615,635 | $31,198,473 | $2,246 | - |
| Current Liabilities | $64,592,834 | $66,196,788 | $56,018,196 | $42,610,356 |
| Other Current Liabilities | $350,444 | $8,800,404 | - | - |
| Current Deferred Liabilities | $40,679,546 | $20,398,742 | $20,473,998 | $18,615,074 |
| Payables And Accrued Expenses | $18,590,363 | $30,974,952 | $29,049,759 | $18,506,122 |
| Payables | $15,736,269 | $13,508,930 | $16,279,906 | $12,447,490 |
| Other Payable | $688,532 | $754,802 | $471,751 | $548,130 |
| Total Tax Payable | $7,656,970 | $7,717,623 | $8,288,218 | $7,407,615 |
| Accounts Payable | $7,390,767 | $5,036,505 | $7,519,937 | $4,491,744 |
| Equity | ||||
| Common Stock Equity | $-94,892,733 | $-73,798,720 | $-2,071,212 | $-30,377,401 |
| Total Equity Gross Minority Interest | $-94,892,733 | $-73,798,720 | $-2,071,212 | $-30,377,401 |
| Stockholders Equity | $-94,892,733 | $-73,798,720 | $-2,071,212 | $-30,377,401 |
| Gains Losses Not Affecting Retained Earnings | $-422,492,421 | $-349,892,173 | $-310,088,736 | $-254,500,732 |
| Other Equity Adjustments | $-422,492,421 | $-349,892,173 | $-310,088,736 | $-254,500,732 |
| Retained Earnings | $-26,913,400 | $-76,527,014 | $-44,591,711 | $-64,069,415 |
| Other | ||||
| Treasury Shares Number | $24,843 | $24,843 | $24,843 | $24,843 |
| Ordinary Shares Number | $54,350,163 | $53,245,797 | $52,916,107 | $39,148,326 |
| Share Issued | $54,375,007 | $53,270,641 | $52,940,951 | $39,173,169 |
| Tangible Book Value | $-94,903,966 | $-73,806,582 | $-2,080,198 | $-30,378,524 |
| Invested Capital | $8,690,329 | $-21,375,941 | $49,016,062 | $23,130,406 |
| Working Capital | $5,889,026 | $2,842,862 | $42,082,444 | $16,199,034 |
| Capital Lease Obligations | $3,480,849 | $4,751,207 | $5,708,188 | $6,211,389 |
| Total Capitalization | $5,209,480 | $-25,490,284 | $44,722,004 | $19,089,071 |
| Treasury Stock | $256,093 | $256,093 | $256,093 | $256,093 |
| Additional Paid In Capital | $353,138,270 | $351,278,223 | $351,277,100 | $287,273,954 |
| Capital Stock | $1,630,911 | $1,598,338 | $1,588,229 | $1,174,885 |
| Common Stock | $1,630,911 | $1,598,338 | $1,588,229 | $1,174,885 |
| Employee Benefits | $569,471 | $485,230 | $362,799 | $303,269 |
| Non Current Pension And Other Postretirement Benefit Plans | $569,471 | $485,230 | $362,799 | $303,269 |
| Long Term Capital Lease Obligation | $2,121,757 | $3,334,831 | $4,361,451 | $5,130,855 |
| Current Deferred Revenue | $40,679,546 | $20,398,742 | $20,473,998 | $18,615,074 |
| Current Capital Lease Obligation | $1,359,092 | $1,416,377 | $1,346,737 | $1,080,535 |
| Current Provisions | $132,540 | $491,969 | $853,645 | $367,292 |
| Current Accrued Expenses | $2,854,094 | $17,466,023 | $12,769,853 | $6,058,632 |
| Net PPE | $5,128,608 | $6,220,375 | $7,021,229 | $7,997,304 |
| Accumulated Depreciation | $-13,973,941 | $-12,378,973 | $-10,626,755 | $-9,187,914 |
| Gross PPE | $19,102,550 | $18,599,349 | $17,647,984 | $17,185,219 |
| Construction In Progress | $719,982 | $439,178 | $211,165 | $386,387 |
| Other Properties | $2,908,009 | $2,801,303 | $2,614,849 | $2,389,082 |
| Machinery Furniture Equipment | $5,290,352 | $5,220,712 | $4,939,908 | $4,903,965 |
| Buildings And Improvements | $10,184,208 | $10,138,156 | $9,882,062 | $9,504,661 |
| Properties | $0 | $0 | $0 | $0 |
| Investments And Advances | - | - | $0 | $0 |
| Available For Sale Securities | - | - | - | - |
Fetched: 2026-10-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-38,153,432 | $-22,912,502 | $-14,391,778 | $-41,779,176 |
| Operating Activities | ||||
| Operating Cash Flow | $-37,540,155 | $-21,960,014 | $-14,013,254 | $-41,674,717 |
| Cash Flow From Continuing Operating Activities | $-37,539,032 | $-21,960,014 | $-14,014,377 | $-41,676,963 |
| Operating Gains Losses | $171,852 | $-3,370 | $-26,957 | $3,370 |
| Investing Activities | ||||
| Capital Expenditure | $-613,276 | $-952,488 | $-378,524 | $-104,459 |
| Investing Cash Flow | $-649,219 | $-1,072,672 | $-392,003 | $155,004 |
| Cash Flow From Continuing Investing Activities | $-649,219 | $-1,072,672 | $-392,003 | $153,881 |
| Net Other Investing Changes | - | - | - | $1,123 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $1,724,138 | $0 | $67,565,989 | $0 |
| Financing Cash Flow | $42,026,284 | $-5,767,719 | $52,533,978 | $-6,347,299 |
| Cash Flow From Continuing Financing Activities | $42,027,407 | $-5,767,719 | $52,533,978 | $-6,346,175 |
| Net Other Financing Charges | $-873,863 | - | $-3,133,775 | $-1,123 |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Net Common Stock Issuance | $1,724,138 | $0 | $67,565,989 | $0 |
| Common Stock Issuance | $1,724,138 | $0 | $67,565,989 | $0 |
| Other | ||||
| Repayment Of Debt | $-5,328,541 | $-4,666,966 | $-4,228,912 | $-5,318,432 |
| Issuance Of Debt | $48,223,071 | $0 | $168,483 | $0 |
| End Cash Position | $59,249,691 | $55,865,439 | $84,559,138 | $46,487,701 |
| Beginning Cash Position | $55,865,439 | $84,559,138 | $46,487,701 | $94,261,485 |
| Effect Of Exchange Rate Changes | $-451,533 | $105,582 | $-57,284 | $93,227 |
| Changes In Cash | $3,835,786 | $-28,799,281 | $38,128,721 | $-47,867,011 |
| Interest Paid Cff | $-1,718,522 | $-1,100,753 | $-7,837,808 | $-1,027,743 |
| Net Issuance Payments Of Debt | $42,894,530 | $-4,666,966 | $-4,060,429 | $-5,318,432 |
| Net Long Term Debt Issuance | $42,894,530 | $-4,666,966 | $-4,060,429 | $-5,318,432 |
| Long Term Debt Payments | $-5,328,541 | $-4,666,966 | $-4,228,912 | $-5,318,432 |
| Long Term Debt Issuance | $48,223,071 | $0 | $168,483 | $0 |
| Net Investment Purchase And Sale | $-35,943 | $-120,184 | $-13,479 | $258,340 |
| Net Intangibles Purchase And Sale | $-8,986 | $-2,246 | $-10,109 | $-1,123 |
| Purchase Of Intangibles | $-8,986 | $-2,246 | $-10,109 | $-1,123 |
| Net PPE Purchase And Sale | $-604,291 | $-950,241 | $-368,415 | $-103,336 |
| Purchase Of PPE | $-604,291 | $-950,241 | $-368,415 | $-103,336 |
| Taxes Refund Paid | $-222,397 | $-69,639 | $-7,863 | $0 |
| Change In Working Capital | $-3,820,061 | $16,042,907 | $11,142,312 | $2,582,276 |
| Change In Other Working Capital | $-17,971 | $13,695,384 | $1,810,626 | - |
| Change In Other Current Liabilities | $196,563 | $-251,601 | $812,086 | $1,370,325 |
| Change In Payables And Accrued Expense | $-6,077,727 | $2,200,382 | $9,743,907 | $3,262,945 |
| Change In Payable | $-6,077,727 | $2,200,382 | $9,743,907 | $3,262,945 |
| Change In Receivables | $2,079,074 | $398,742 | $-1,224,306 | $-2,050,994 |
| Changes In Account Receivables | $943,502 | $-2,325,059 | $-905,313 | $-113,445 |
| Other Non Cash Items | $-12,161,069 | $32,130,743 | $13,449,399 | $14,216,556 |
| Stock Based Compensation | $3,975,065 | $4,827,586 | $3,619,005 | $3,565,090 |
| Provisionand Write Offof Assets | $-252,724 | $-295,406 | $568,348 | $342,581 |
| Deferred Tax | $3,370 | $113,445 | $134,786 | $0 |
| Deferred Income Tax | $3,370 | $113,445 | $134,786 | $0 |
| Depreciation Amortization Depletion | $1,679,209 | $1,820,735 | $1,699,427 | $1,684,825 |
| Depreciation And Amortization | $1,679,209 | $1,820,735 | $1,699,427 | $1,684,825 |
| Net Income From Continuing Operations | $-26,913,400 | $-76,527,014 | $-44,591,711 | $-64,069,415 |
| Proceeds From Stock Option Exercised | - | - | $0 | $0 |
| Purchase Of Investment | - | - | - | - |
Fetched: 2026-10-20